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ABSTRACT 
 
The importance of Wnt pathway signaling in development of bone has been well established. Here we 
investigated the role of a known Wnt target, ENC1 (ectodermal-neural cortex 1; NRP/B), in osteoblast 
differentiation. Enc1 expression was detected in mouse osteoblasts, chondrocytes and osteocytes by in 
situ hybridization, and osteoblastic expression was verified in differentiating primary cultures and 
MC3T3-E1 pre-osteoblast cells, with 57kDa and 67kDa ENC1 protein isoforms detected throughout 
differentiation. Induced knockdown of both ENC1 isoforms reduced alkaline phosphatase staining and 
virtually abolished MC3T3-E1 mineralization. At culture confluence, Alpl (alkaline phosphatase 
liver/bone/kidney) expression was markedly reduced compared with control cells, and there was 
significant and coordinated alteration of other genes involved in cellular phosphate biochemistry. In 
contrast, with 67kDa-selective knockdown mineralized nodule formation was enhanced and there was a 
2-fold increase in Alpl expression at confluence. There was enhanced expression of Wnt/β-catenin target 
genes with knockdown of both isoforms at this time-point and a 5-fold increase in Frzb (Frizzled related 
protein) with 67kDa-selective knockdown at mineralization, indicating possible ENC1 interactions with 
Wnt signaling in osteoblasts.  These results are the first to demonstrate a role for ENC1 in the control of 
osteoblast differentiation. Additionally, the contrasting mineralization phenotypes and transcriptional 
patterns seen with coordinate knockdown of both ENC1 isoforms vs selective knockdown of 67kDa 
ENC1 suggest opposing roles for the isoforms in regulation of osteoblastic differentiation, through effects 
on Alpl expression and phosphate cellular biochemistry. This study is the first to report differential roles 
for the ENC1 isoforms in any cell lineage. This article is protected by copyright. All rights reserved 
 
  
A
cc
ep
te
d
 A
rt
ic
le
   
This article is protected by copyright. All rights reserved 
INTRODUCTION 
  
It is now understood that the Wnt pathway plays an important role in osteoblast differentiation and bone 
development, and understanding this mechanism will be advantageous as the Wnt pathway becomes a 
focus for potential anabolic therapeutics [Shah et al., 2015]. Enc1 is a Wnt target gene [Fujita et al., 2001] 
implicated in the control of differentiation along several cell lineages [Kim et al., 2009; Kim et al., 1998; 
Zhao et al., 2000]. For example, reduction of Enc1 expression by RNA interference inhibited neuronal 
differentiation in vitro [Kim et al., 1998]. Proposed mechanisms for a neuronal ENC1 function include 
binding to Retinoblastoma protein (RB1), thereby leading to cell cycle withdrawal [Kim et al., 1998], and 
ENC1 acting as a nuclear matrix protein via actin binding [Liang et al., 2004]. Knockdown of Enc1 
similarly inhibited adipocyte differentiation in vitro [Zhao et al., 2000], with actin binding by ENC1 a 
proposed requisite for cytoskeletal changes during adipocyte maturation.  
 
ENC1 is a member of the BTB-Kelch family, with conserved amino terminal BTB/POZ and carboxy 
terminal Kelch protein interaction domains [Prag and Adams, 2003] linked by an intervening BACK 
domain in some family members [Stogios and Prive, 2004]. Some BTB-Kelch proteins are implicated in 
cellular functions requiring cytoskeletal stability [Ding et al., 2002; Jiang et al., 2005; Robinson and 
Cooley, 1997]. Several have been found to serve as adapters to target specific substrate proteins for E3 
ubiquitin ligase mediated regulation or proteasomal degradation [Angers et al., 2006; Kobayashi et al., 
2004; Metzger et al., 2013]. A few family members appear to provide both functions [Kang et al., 2004; 
Salinas et al., 2006]. Human and mouse ENC1 proteins share 98% amino acid homology [Hernandez et 
al., 1998]. Two ENC1 protein species of 67kDa and 57kDa were immunologically detected in rat primary 
neurons and in rat and human neuroblastoma cell lines, with the 67kDa polypeptide attributed to the full 
length coding region [Kim et al., 1998] and subsequent functional studies of ENC1 focused on this 
isoform. A shorter amino-terminally truncated isoform of human ENC1 was predicted by bioinformatic 
analysis [Resch et al., 2004] but, to date, no mouse 57kDa ENC1 homolog has been reported.  
 
Investigations into the molecular details of ENC1 protein function have largely been driven by its BTB-
Kelch domain structure. Like other BTB-Kelch proteins full length 67kDa ENC1 has been found to co-
localize with cytoplasmic actin [Hernandez et al., 1997; Liang et al., 2004; Zhao et al., 2000], but also to 
bind in vitro to nuclear proteins RB1 [Kim et al., 1998], E2F transcription factor and histone deacetylase 
1 (HDAC1) [Choi et al., 2014], and NFE2-related factor 2 (NRF2) [Seng et al., 2010; Seng et al., 2007]. 
In addition, there is some evidence that ENC1 may act as an E3 ligase substrate adaptor [Zhang et al., 
2005], although no specific target protein has yet been identified for this potential role. A recent report 
also found that ENC1 interacts with p62 in neuronal cells during ER stress [Lee et al., 2016]. Functional 
attributes of the 57kDa ENC1 isoform have not yet been tested. 
 
Although a specific role for ENC1 in bone cell biology has not previously been investigated, Enc1 was 
one of several Wnt related genes in mouse bone that responded to spinal cord injury [Sun et al., 2013]. As 
ENC1 has been implicated in adipose and neuronal cell differentiation, we investigated the potential 
involvement of ENC1 in the regulation of osteoblastic differentiation, as well as the possibility that the 
two protein isoforms might have distinguishable roles in this context. 
 
MATERIALS AND METHODS 
 
In situ hybridization   
For riboprobe preparation, a sequence corresponding to nucleotides 777-1264 in the coding region of the 
human ENC1 gene (NM_003633) was amplified by RT-PCR from MG63 (RRID:CVCL_0426) cDNA 
using hEnc1 primers 5’-GCTGGAGTTTCAAGACATCC-3’ and 5’-GGGCACAGAGGCTGGTTACC-
3’ and cloned into pBluescript SK+ (Stratagene). Sense and antisense riboprobes labeled with 
digoxigenin-uridine triphosphate (Roche Applied Science) were prepared by in vitro transcription. In situ 
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hybridization was performed on sections of paraffin embedded decalcified adult mouse distal femur using 
a modified protocol [Sims et al., 1997]. Sections were permeabilized in 0.3% triton X-100/PBS for 20 
min at RT and then incubated with 10ug/ml Proteinase K at 37°C for 15 min. Sections were pre-
hybridized at 42°C for 30 min and hybridized with riboprobe (60ng) at 42°C overnight. Prior to detection, 
sections were incubated in 20ug/ml RNase A (Roche Applied Science) before DIG-labeled transcripts 
were detected according to manufacturer’s protocol (Roche Applied Science).  
 
Cell Culture  
Tissue culture medium and supplements were purchased from Invitrogen (Life Technologies). All culture 
media were supplemented with heat inactivated FBS (JRH Biosciences or Hyclone, Thermo Scientific). 
Primary calvarial osteoblast cultures were prepared from 3 day old FVB/N mice (n=30) based on a 
protocol previously described [Thomas et al., 2000]. Bone fragments underwent 3 sequential digests in 
0.1% collagenase A (Roche Applied Science)/ 0.05% trypsin (CSL)/0.02% EDTA/PBS for 30 min then 
demineralization for 10 min in 4mM EDTA/PBS. Further cell release was obtained by incubation of 
fragments with 1mg/ml collagenase/PBS for 45 min. The latter two incubations were repeated to obtain a 
total of seven cell populations, which were pooled and seeded at 1x104 cells/cm2 in α-MEM with 10% 
FBS, 2mM L-glutamine, 2.2g/L NaHCO3, 10mM β-glycerophosphate, 50mg/L ascorbic acid and 
100U/ml penicillin/streptomycin. MC3T3-E1 sub-clone 14 (ATCC, Cat# CRL-2594, RRID:CVCL_5437) 
cells (MC3T3) and MC3T3 stable lines expressing Enc1 shRNA were maintained in growth media (α-
MEM with 10% FBS, 2mM L-glutamine and 20mM HEPES). shRNA production was induced in MC3T3 
lines by treatment with 2µg/ml doxycycline (dox) which was replenished at each media change. For 
differentiation, cells were seeded at 0.7x104 cells/cm2 in growth media supplemented with 10mM β-
glycerophosphate and 50mg/L ascorbic acid.  All cells were cultured at 37°C and 5% CO2. 
 
Alizarin Red staining and Alkaline Phosphatase assay  
MC3T3 culture mineralization was assessed by Alizarin staining; cultures were fixed in 10% 
paraformaldehyde/PBS and stained with 2% Alizarin Red S (pH 4.2) for 10 min. Images were collected 
on the Perfection V700 Photo scanner (Epson). Alizarin stain was subsequently eluted in 10% 
cetylpyridinium chloride for 1h and quantitated at 540nm. For alkaline phosphatase (ALP) staining, 
cultures were fixed in 4% paraformaldehyde/PBS for 5 minutes then enzymatic activity was detected 
using the Alkaline Phosphatase staining kit (Sigma Aldrich), and imaged as above.  
 
RNA preparation and quantitative RT-PCR 
Total RNA was extracted from osteoblastic cells using the TRIzol reagent (Invitrogen) and treated with 
DNase I using the DNA-free kit (Ambion). cDNA was synthesized using Superscript III reverse 
transcriptase (Invitrogen) and quantitative RT-PCR was performed using SYBR green and the Rotor-gene 
RG-3000, Rotor-gene RG-6000 (Corbett Life Science), ABI Prism 7900HT Sequence Detection System 
or ViiA7 Real-Time PCR System (Applied Biosystems; Life Technologies). Relative gene expression 
levels were quantiﬁed using the 2^(-∆∆CT) method with cyclophilin or β‐actin as the housekeeping gene. 
Primer sequences are shown in Table 1. 
 
Antibodies and immunoblotting 
To assess protein levels in cells, total cellular protein was isolated in RIPA buffer (50mM Tris-HCl, pH8, 
150mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS). Total cell lysates were quantitated 
using BCA protein assay reagents (Thermo Scientific). Samples were resolved by electrophoresis in 4-
12% NuPAGE gels (Invitrogen) and transferred to PVDF membranes (GE Healthcare). Membranes were 
probed with ENC1 antibody (Santa Cruz Biotechnology Cat# sc-135896 RRID:AB_2293504), and β-
actin (Abcam Cat# ab8227, RRID:AB_2305186) was used as a loading control. Bound primary 
antibodies were detected by chemiluminescent detection of HRP-conjugated secondary antibodies (GE 
Healthcare) and results quantitated using Image J software. 
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Statistical Analysis 
All data analyses were performed in the open source statistical environment R (http://www.R-
project.org/). One- or Two-way ANOVA analyses were performed depending on the data set. Fisher’s 
PLSD post hoc tests were executed on main effects. Data are graphed as mean ± SE. Comparisons are 
indicated in the figure legends. Significance values are represented: *P<0.05, **P<0.01, ***P<0.001; 
#P<0.05, ##P<0.01, ###P<0.001. 
 
 
RESULTS 
 
Enc1 is expressed in osteoblasts and osteocytes 
The cellular pattern of Enc1 expression in adult mouse distal femur was determined histologically. Enc1 
transcripts were localized in mature periosteal osteoblasts, osteocytes, articular and growth plate 
chondrocytes, and in cells of the perichondrial Groove of Ranvier (Fig. 1A). Osteoblastic Enc1 expression 
was confirmed in differentiating primary mouse calvarial cultures and in differentiating cultures of the 
pre-osteoblastic MC3T3 cell line (Fig. 1B), where mRNA was detected throughout culture phases of pre-
confluent proliferation, matrix formation and matrix mineralization. In both cell types there was a 
significant decrease (by one-way ANOVA; p<0.05) in expression compared with levels at day 2 (at all 
time-points except days 8, 21, 22 for primary cultures; and at all time-points for MC3T3 cells). As the 
Enc1 primers used for transcriptional analysis did not distinguish between encoded isoforms, the ENC1 
protein profile during MC3T3 differentiation was analyzed (Fig. 1C). Two isoforms of the ENC1 protein 
were observed throughout 21 days of osteoblastic culture, with estimated mass of 67kDa and 57kDa 
compared with protein standards as previously found in primary neurons [Kim et al., 1998]. At later 
differentiation days (from day 12 onward) there was significantly more full length isoform than 57kDa 
ENC1 (Fig. 1D).  
 
Knockdown of the ENC1 isoforms has graded effects on MC3T3 mineralization 
As Enc1 was expressed throughout MC3T3 osteoblastic differentiation the effect of ENC1 knockdown 
during osteogenesis was investigated using a doxycycline-inducible shRNA knockdown approach [Brown 
et al., 2010]. MC3T3 lines inducibly expressing Enc1 shRNA were prepared as described in the 
Supplementary data and validated (Suppl. Fig.1). These lines express shRNA targeted to inhibit 
production of 67kDa ENC1 (line A) or shRNA targeted to inhibit both 57kDa and 67kDa ENC1 products 
(line B, C, D), in addition to a scrambled GFP (scGFP) control. The studies reported in this paper focused 
on ENC1 shRNA A and C lines.   
 
In the absence of doxycycline, all cell lines exhibited comparable mineralization at differentiation day 21, 
the experimental endpoint (Fig 2A; column 1). With continuous induction of shRNA from Day 0 of 
differentiation, there was a striking increase in mineralization of the shRNA A line cultures compared 
with untreated controls (Fig. 2A; compare columns 1 and 2), confirmed by quantitation of eluted Alizarin 
Red staining (Fig. 2B). In contrast, under the same conditions there was an almost complete inhibition of 
mineralization in cultures of the shRNA C line, and in the two independent cell lines prepared using 
shRNA B and D sequences (Suppl. Fig. 2) that also knock down both 57kDa/67kDa ENC1 (Suppl. Table 
2; Suppl. Fig 1). A modest increase in culture mineralization with expression of the scGFP shRNA 
sequence was presumably due to off target effects, as this control shRNA had no effect on Enc1 mRNA 
and protein levels (Suppl. Fig. 1).  
 
To map the stage of differentiation when these ENC1 knockdown effects occurred, shRNA production 
was induced at later stages of osteogenesis (D5, 9, 13 and 18; Fig 2A, columns 3-6). Enhanced 
mineralized nodule formation in the shRNA A cultures was still observed with delayed induction of dox 
treatment at day 5 or 9, however induction at day 13 or later failed to show an effect of this shRNA on 
osteoblast differentiation. A significant inhibitory effect of shRNA C on mineralized nodule formation 
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persisted with delayed induction out to day 13, but was lost with shRNA induction at day 18. The level of 
mineralization in the shRNA A and C cell lines was significantly increased or decreased respectively, 
compared with the scGFP line, after multiple timepoints of induction (A, dox D0, 5; C, dox D0, 5, 9, 13). 
Doxycycline treatment at any day had little effect on mineralized nodule formation by the parental 
MC3T3 line. 
 
Transient expression of ENC1 isoforms alters MC3T3 mineralization 
As another test of the contribution of the ENC1 isoforms on MC3T3 differentiation, these cells were 
transiently transfected, on day 1, with ENC1 expression vectors encoding either 57 or 67kDa forms of the 
protein (cloned as described in the Supplementary data) or the pcDNA5/FRT/TO vector control. When 
cells were transfected with p57, there were significantly more Alizarin Red stained nodules at day 21 
compared to cells expressing the p67 protein (Fig. 3A). The area of mineralization was likewise increased 
in the cells transfected with p57 compared with p67 ENC1 (Fig. 3B). Additionally, mineralization was 
significantly lower in the cells expressing p67 compared to cells transfected with the empty vector 
control.  
 
Knockdown of ENC1 changes Alpl expression and ALP enzymatic activity levels 
To further investigate the effect of ENC1 knockdown on MC3T3 differentiation, ALP activity was 
assessed (Fig. 4A). There was stronger ALP staining in cultures with induction of shRNA A compared to 
levels seen in both the MC3T3 parental cells and those expressing shRNA C, which mirrored enhanced 
mineralization results, and was evident as early as D6 of differentiation. In contrast there was an almost 
complete inhibition of ALP staining at all time-points assessed in shRNA C expressing cells. Levels of 
Alpl transcripts were consistent with the ALP staining pattern, with significant main effects of cell line, 
differentiation day and interaction (Fig. 4B). 
 
Knockdown of ENC1 isoforms coordinately affects osteoblastic gene expression 
Expression of osteoblastic genes was assessed in the shRNA lines at the stages of MC3T3 culture 
confluence (D3) and onset of mineralization (D13). After 3 days of differentiation, ENC1 knockdown had 
no effect on transcript levels for osteoblast marker genes Runx2 (runt related transcription factor 2) and 
Col1a1 (collagen, type 1, alpha 1); however, knockdown of both ENC1 isoforms in the shRNA C line led 
to decreased expression of osterix (Sp7) and Ibsp (integrin- binding sialoprotein) compared to the scGFP 
control (Fig. 4A). At this time point, knockdown of 67kDa ENC1 in the shRNA A cells resulted in 
increased expression of osteocalcin (Bglap2) but no other marker gene expression changes. At D13 the 
levels of Sp7 and Bglap2 transcripts were reduced with knockdown of both ENC1 isoforms in the shRNA 
C expressing cells, and there was a decline in Ibsp expression that did not reach statistical significance. 
As at D3, there was increased Bglap2 in the shRNA A cell line, but there was also an increase in Runx2, 
Sp7 and Ibsp levels at D13, unlike the earlier time point.  
 
As there were striking effects of ENC1 knockdown on MC3T3 mineralization, genes involved in 
phosphate biochemistry were next assessed (Fig. 5B). At D3 in the shRNA C cells, there was decreased 
expression of Alpl and Phospho1 (phosphatase, orphan 1), and increased expression of Ank (progressive 
ankylosis), Enpp1 (ectonucleotide pyrophosphatase/phosphodiesterase 1) and osteopontin (Spp1) 
compared to the scGFP control. Conversely, there was an increase in Alpl expression with targeted 
knockdown of 67kDa ENC1 at this early timepoint, although the other genes involved in phosphate 
biochemistry tested here were not affected by this selective interference. At the onset of mineralization at 
D13, there were decreased levels of Phospho1 transcripts in cells producing shRNA C and a trend for a 
decrease in Alpl expression (p=0.08), as was seen at D3. In the shRNA A cultures the expression levels of 
these two genes were increased, as were levels of Enpp1 and Spp1 transcripts. No changes in Ank mRNA 
levels were seen at this time point. 
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Expression of genes involved in Wnt pathway signaling were also investigated. At D3 there was increased 
expression of Jun (jun proto-oncogene) and decreased levels of Dkk3 (dickkopf WNT signaling pathway 
inhibitor 3) in cells expressing the shRNA C compared to the control scGFP cells. There was also 
decreased expression of Dkk3 with selective knockdown of 67kDa ENC1 at this time. There was 
significantly greater expression of Jun, Fosl1 (fos-like antigen 1) and Dkk2 (dickkopf WNT signaling 
pathway inhibitor 2) in the shRNA C cells compared with the shRNA A cells at this early time point. At 
D13, levels of Axin2, Jun and Sfrp2 (secreted frizzled-related protein 2) were decreased, and Frzb mRNA 
was increased with targeted knockdown of 67kDa ENC1. Furthermore, Myc (myelocytomatosis 
oncogene) mRNA was lower, and Jun, Sfrp2 and Dkk2 were higher in the shRNA C cells. Expression 
levels of Axin2, Myc, Sfrp2, Frzb and Dkk2 mRNA were significantly different between the shRNA A 
and C lines at this time point. 
 
DISCUSSION 
 
While the broad concepts underlying osteoblast differentiation are well understood, details clarifying the 
complexities of osteogenesis continue to emerge. As ENC1 was important in the differentiation of other 
cell lineages including closely related adipocytic cells [Kim et al., 1998; Zhao et al., 2000], we have 
analyzed the possible role of ENC1 in osteoblasts using an inducible-knockdown approach in vitro after 
confirming Enc1 expression in mouse bone by in situ hybridization. We obtained histological and 
functional evidence supporting a regulatory role for ENC1 in osteoblast differentiation. In addition, we 
identified distinct osteoblastic mineralization patterns in vitro with differential knockdown of 67kDa 
ENC1 alone, or of 67kDa and 57kDa ENC1 together, for the first time revealing functional differences for 
the two ENC1 protein isoforms.  
 
While there was a marked increase in MC3T3 mineralization with knockdown of 67kDa ENC1 and a 
striking decrease with knockdown of both ENC1 isoforms, there was no change in expression of the 
master osteoblastic transcription factor Runx2 at culture confluence. However, there was reduced 
expression of the regulatory gene Sp7 and the bone matrix component Ibsp at early stages after 
knockdown of both ENC1 isoforms, suggesting that although ENC1 may not act at the level of osteoblast 
commitment (i.e. through Runx2 expression), it may regulate the progress of osteoblast differentiation. 
Both Ibsp [Li et al., 2010] and Sp7 [Nishio et al., 2006] are RUNX2 target genes, and as RUNX2 is 
subject to phosphorylation [Li et al., 2016] and other post translational modifications [Jonason et al., 
2009] that affect protein stability and transcriptional activity, these reduced mRNA levels early in MC3T3 
differentiation, may reflect an effect of ENC1 knockdown on RUNX2 activity that remains to be 
elucidated.   
 
Knockdown of ENC1 also had an early and coordinated effect on the expression of genes involved in 
phosphate metabolism and transport. Osteoblast mineralization is initiated in an orchestrated process 
involving an extracellular balance of available inorganic phosphate (Pi) which is a mineralization 
substrate, and pyrophosphate (PPi), an inhibitor of calcification. PPi is generated by the membrane 
glycoprotein ENPP1 [Johnson et al., 1999], exported from the cell by membrane transporter ANK [Ho et 
al., 2000], and converted into Pi in the extracellular space by ALPL [Johnson et al., 2000]. PHOSPHO1 
also generates Pi in a non-redundant process, with the hydrolysis of phosphoethanolamine and 
phosphocholine in matrix vesicles [Yadav et al., 2011]. Maintenance of a physiological level of 
extracellular PPi is also important to prevent pathologic calcification of un-mineralized tissues including 
cartilage and vascular cells [Ho et al., 2000; Huang et al., 2008; Orimo, 2010].   
 
With our knockdown of both 67kDa and 57kDa ENC1 in the shRNA C line we saw decreased expression 
of Alpl and Phospho1 in early osteoblastic differentiation along with marked increases in expression of 
Ank and Enpp1. This set of expression changes suggest a mechanism for the failure of these cells to 
mineralize by increasing extracellular PPi levels and reducing available Pi. In these shRNA C cells, we 
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also saw increased expression of the extracellular matrix protein OPN, which directly binds to and 
inhibits the growth of mineralized crystals [Addison et al., 2007; Wada et al., 1999]. PPi treatment of 
MC3T3 cells can increase Opn expression [Addison et al., 2007], providing further support for a 
disruption of phosphate homeostasis in our shRNA C cultures. Conversely, increased ALPL levels at this 
early time point may help to explain the increased mineralization phenotype observed in the shRNA A 
cell cultures with targeted knockdown of only 67kDa ENC1. Our delayed induction of shRNA expression 
during the process of MC3T3 differentiation suggested that the window of vulnerability of these cells to 
ENC1 knockdown appears to close around the time of mineralization detection. As it has previously been 
demonstrated that alterations of PPi/Pi levels in early osteoblast cultures result in modulated downstream 
responses in mineralizing cultures through temporally regulated transcriptional and signaling events 
[Camalier et al., 2013], our observed early changes in expression of genes involved in PPi/Pi generation 
suggest a likely mechanism for the MC3T3 mineralization phenotypes that appeared as a result of ENC1 
knockdown. 
 
Alterations in early regulation of canonical Wnt/β-catenin signaling as a result of ENC1 knockdown 
appear mixed. The increase in expression of Jun and Fosl1 target genes in the C line suggests that 
canonical Wnt pathways may be more in play in this cell line compared with cells expressing shRNA A. 
In our studies and those of others canonical Wnt signaling has an inhibitory effect on differentiation of 
MC3T3 and other osteoblastic cells (data not shown; [Eijken et al., 2008; Shi et al., 2007; van der Horst et 
al., 2005]), so increased expression of these canonical Wnt targets may feed into our observed low 
mineralization phenotype in this cell line. This up-regulation of canonical targets did not however extend 
to genes such as Cdnd1 and Myc involved in cell cycle regulation. Consistently, we did not see any effect 
of ENC1 knockdown on cell proliferation (data not shown). Dkk2, though not a widely reported canonical 
Wnt target gene, has been found to be upregulated in MC3T3 cells upon treatment with canonical WNT1 
[Li et al., 2005] and was also markedly upregulated in the shRNA C expressing cells. Interestingly, on the 
other side of the coin, in the cells with targeted knockdown of 67kDa ENC1 there was a marked increase 
in Frzb expression at D13. Treatment with FRZB has been shown to enhance osteoblast differentiation 
[Chung et al., 2004], and stable overexpression of FRZB in MC3T3 cells resulted in increased 
osteogenesis together with reduced canonical and increased non-canonical Wnt signaling [Thysen et al., 
2016]. Concurrent decreases in expression of canonical Wnt signaling target genes Axin2 and Jun suggest 
that a switch from canonical to non-canonical Wnt signaling in cells with targeted 67kDa ENC1 
knockdown may be contributing to the enhanced mineralization phenotype that we see in these cells.  The 
opposing patterns of expression of these genes involved in Wnt signaling in the A and C cell lines is 
compelling and warrants future investigation to determine the effect of the ENC1 isoforms in both 
canonical and non-canonical Wnt signaling pathways during MC3T3 differentiation.  
 
The inhibition of MC3T3 cell differentiation with general knockdown of both ENC1 isoforms is 
consistent with previous studies in neuronal [Kim et al., 1998] and adipocyte [Zhao et al., 2000] cell 
lineages and suggests that regulatory mechanisms affected by ENC1 may be similar in diverse cellular 
contexts. A possible mechanism by which ENC1 might control differentiation of non-osseous as well as 
osteoblastic lineages could be through regulation of Alpl expression. ALP activity was increased during 
adipocyte differentiation and ALPL enzyme inhibition prevented lipid accumulation in 3T3-L1 cells [Ali 
et al., 2005]. In addition, ALPL has been found to be required for axonal growth in primary hippocampal 
neurons [Diez-Zaera et al., 2011]. As ALPL is essential in early stages of skeletal mineralization [Millan, 
2013], the early dysregulation of the Alpl gene in the ENC1 knockdown MC3T3 cell lines may be a driver 
of the observed phosphate gene-related expression and mineralization phenotypes. In this context it is 
noteworthy that overexpression of 67kDa ENC1 in the HT29 colon cancer cell line had an inhibitory 
effect on ALP activity and caused a corresponding decrease in cellular differentiation [Fujita et al., 2001]. 
Although mechanistic aspects of these effects remain to be determined, the consistency of ENC1 
overexpression and knockdown phenotypes reinforces the concept that any alteration in ENC1 level and 
isoforms may significantly alter cell physiology in multiple lineages.  
A
cc
ep
te
d
 A
rt
ic
le
   
This article is protected by copyright. All rights reserved 
 
Several limitations should be considered when interpreting the findings of this study. First, interpretation 
of the 57kDa ENC1 isoform knockdown is confounded by coordinate knockdown of the full length 
67kDa isoform. While there was a reversal of the mineralization phenotype when 57kDa or 67kDa ENC1 
isoforms were transiently transfected into MC3T3 cells, lending credence to the idea that the 
mineralization effects seen with shRNA C expression are due to a knockdown of the 57kDa ENC1 
isoform, a conclusion that inhibition of MC3T3 mineralization and associated dysregulation of phosphate 
biochemistry was specifically due to altered 57kDa ENC1 here can only be inferred at this point. 
Secondly, while changes in the transcription of phosphate involved genes in cells by knockdown of the 
ENC1 isoforms are suggestive of an effect of these proteins on the maintenance of phosphate levels, an 
assessment and investigation of extracellular levels of PPi/Pi will be necessary to directly tie 
mineralization phenotypes to the changes in gene expression in the ENC1 knockdown lines reported here. 
Finally, confirming potential interactions of the ENC1 isoforms with canonical and non-canonical Wnt 
signaling mechanisms, especially in the context of expression of genes involved in phosphate regulation, 
would significantly add to understanding of the control of osteoblast mineralization. 
 
In summary, here we have presented an initial study exploring the effects of the ENC1 isoforms on 
osteoblast differentiation. Our data indicate that the ENC1 gene is expressed and produces two protein 
isoforms throughout osteoblast differentiation. Differential knockdown of these two isoforms suggests 
that they have opposing roles in the process, modulating the expression of Alpl and other genes important 
in cellular phosphate homeostasis and osteoblast mineralization. 
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FIGURE LEGENDS 
Figure 1. Enc1 is expressed in bone and during differentiation of osteoblastic cells. (A) Enc1 transcripts 
were detected in periosteal osteoblasts and cortical osteocytes (a), articular (b) and growth plate (c) 
chondrocytes and in cells of the perichondrial Groove of Ranvier (d) by in situ hybridization of adult 
mouse distal femur sections. (B) Enc1 transcripts (normalized to expression at day 2) were expressed 
throughout differentiation of primary calvarial osteoblasts (top panel) and MC3T3 osteoblastic cells 
(bottom panel). Cells were harvested for RNA preparation (n=2 or 3) at the days shown. Vertical dotted 
lines denote culture confluence and onset of mineralization. Enc1 was detected throughout periods of pre-
confluence (P), matrix formation (MF) and mineralization (MIN). (C) Two isoforms of the ENC1 protein 
were detected during MC3T3 differentiation by western blotting. Blot is representative of three replicate 
experiments. (D) ENC1 isoform bands were quantitated relative to β-actin using Image J software. 
Results for 67 and 57kDa isoforms are presented in grey and black respectively. #57kDa vs. 67kDa Enc1.  
Figure 2. Knockdown of ENC1 isoforms alters MC3T3 cell differentiation. MC3T3 parental and cell lines 
inducibly expressing shRNA sequences A, C and scGFP were differentiated in the presence or absence of 
2µg/µl dox. (A) Cells were cultured without dox treatment (column 1) or in the presence of dox from 
differentiation days as shown (columns 2-6). At D21 of differentiation all cultures were stained with 
Alizarin Red and (B) levels of eluted stain were spectrophotometrically quantitated (n=3). There were 
significant main effects of cell line and day of induction, and an interaction between these effects 
(p<0.001). Results are representative of two independent experiments. * vs. no dox; # vs. scGFP. 
 
Figure 3. Transient expression of ENC1 isoforms alters MC3T3 mineralization. MC3T3 cells at D1 were 
transiently transfected with expression constructs encoding full-length (p67) or 57kDa (p57) ENC1 
isoforms or the pcDNA5 empty vector. Cells were grown in differentiation media and stained with 
Alizarin Red on D21. Nodule number (A) and mineralization area (B) were quantitated using Image J 
software, and presented relative to signal seen in pcDNA5 transfected cells (dotted line). Results are 
combined from three independent experiments. * vs. p67; # vs. pcDNA5. 
 
Figure 4. Knockdown of ENC1 isoforms alters alkaline phosphatase levels. MC3T3 parental cells and the 
stable cell lines induced to express shRNA sequences A, C and scGFP were differentiated in the presence 
of 2µg/µl dox. (A) At the time-points shown, cells were harvested and stained for ALP activity. (B) Alpl 
transcription was analyzed in the cell lines after differentiation for 3, 6 and 13 days (n=3). Levels were 
quantitated from shRNA A (blue, solid line), shRNA C (red, dotted line) and shRNA scGFP (green, 
dashed line) cells, relative to β-actin housekeeping gene. There were significant main effects of cell line 
and differentiation day, and an interaction between these effects (p<0.001). Results are representative of 
two independent experiments. 
 
Figure 5. Knockdown of ENC1 isoforms alters gene expression. MC3T3 shRNA lines were differentiated 
in the presence of 2µg/µl dox to induce expression of shRNA sequences A, C and scGFP from day of 
plating. Expression of genes involved in Osteoblast differentiation (A), Phosphate biochemistry (B) and 
Wnt pathway signaling (C) were assessed at culture confluence (D3) and onset of mineralization (D13) 
(n=3), relative to β-actin housekeeping gene. mRNA levels in shRNA A (grey bars), and C (black bars) 
lines were normalized to levels seen in the scGFP line (dotted line). Data are representative of two 
independent experiments. #vs. scGFP control; * A vs. C shRNA line. 
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Table 1. Primer sequences used for qRT-PCR in MC3T3 cells 
Target Forward (5’→3’) Reverse (5’→3’) 
Enc1 CTGGTGTATGAGTCTGCGATGAAC GCCTTGGGAATGATTTCTTTAGCC 
Cyclophilin GCCGATGACGAGCCCTTGGGCC ACCAGTGCCATTATGGCGTGTG 
β-actin TCACCCACACTGTGCCCATCTACGA CAGCGGAACCGCTCATTGCCAATGG 
Alpl GCCCTCTCCAAGACATATA CCATGATCACGTCGATATCC 
Runx2 AAGTGCGGTGCAAACTTTCT TCTCGGTGGCTGGTAGTGA 
Sp7 CCCTTCTCAAGCACCAATGG AGGGTGGGTAGTCATTTGCATAG 
Col1a1 AATGGCACGGCTGTGTGCGA AACGGGTCCCCTTGGGCCTT 
Ibsp CGGTTTCCAGTCCAGGGAGGC TTGGGCAGTTGGAGTGCCGC 
Bglap2 CTCTGTCTCTCTGACCTCACAG GGAGCTGCTGTGACATCCATAC 
Phospho1 ACGGAGCAGAAGCACATCATC TAGGCATCGTAGTCCAACAGC 
Ank TCATCCCCGACAGGAGCGGC CCCACGGGGTAGGTGGCTGT 
Enpp1 GTGGTACAAAGGACAGCCGA CTGGTCCATGTGAATGCCCT 
Spp1 TGCACCCAGATCCTATAGCC CTCCATCGTCATCATCATCG 
Axin2 CCTGACCAAACAGACGACGA CACCTCTGCTGCCACAAAAC 
Ccnd1 ACCCTGACACCAATCTCCTCAAC TCTTCGCACTTCTGCTCCTCAC 
Myc GTCTTCCCCTACCCGCTC CTGTCCAACTTGGCCCTC 
Jun TGAGTGACCGCGACTTTTCA GAGGGCATCGTCGTAGAAGG 
Fosl1 GCAAGTGGTTCAGCCCAAGAA GTCCCAGGAAATGAGGCTGC 
Sfrp2 GCCAGCCCGACTTCTCCTACAAG CGGCAGGAGGTGGTCGCTACT 
Frzb ACATTCCAAGGGACACCGTC CCGGGGATTAGAGTTCCTGC 
Dkk2 CCGCTGCAATAATGGAATCT GTAGGCATGGGTCTCCTTCA 
Dkk3 GACACTCAGCACAAACTGCG CCACCTGTCCACTCTGGTTG 
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